Could cause temporary or reversible harm; serious harm is unlikely.
Failed Impurities/Degradation Specifications: Out-of-Specification results obtained for unknown impurities during stability testing.
| Distributed by / for | Breckenridge Pharmaceutical, Inc., Berlin, CT |
| NDC | 51991-643-10 |
| Full product label | Omeprazole Delayed-Release Capsules, USP, 20 mg, 1000 count bottles, Rx Only, distributed by Breckenridge Pharmaceutical, Inc., Berlin, CT, Manufactured by Tow Pharmaceutical Europe, S.L., Martorelles (Barcelona), Spain NDC 51991-643-10 |
| Recalling firm | Breckenridge Pharmaceutical, Inc |
| Distribution | Product was distributed nationwide |
| Quantity | 3,146 bottles |
| Recall initiated | 2021-03-11 |
| Report date | 2021-03-24 |
| Recall completed | 2022-03-23 |
| Recall number | D-0308-2021 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Berlin CT United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗